Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
734 | 3051 | 44.3 | 79% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
612 | 13263 | POLYCYSTIC OVARY SYNDROME//PCOS//HYPERANDROGENISM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HYPOGONADISM | Author keyword | 181 | 34% | 14% | 428 |
2 | LATE ONSET HYPOGONADISM | Author keyword | 127 | 82% | 2% | 75 |
3 | TESTOSTERONE REPLACEMENT THERAPY | Author keyword | 114 | 75% | 3% | 82 |
4 | TESTOSTERONE DEFICIENCY | Author keyword | 108 | 79% | 2% | 70 |
5 | ANDROPAUSE | Author keyword | 75 | 62% | 3% | 78 |
6 | TESTOSTERONE DEFICIENCY SYNDROME | Author keyword | 67 | 89% | 1% | 31 |
7 | ROBERT HAGUE DIABET ENDOCRINOL | Address | 53 | 95% | 1% | 18 |
8 | AGING MALE | Journal | 47 | 37% | 3% | 104 |
9 | ANDROGEN DEFICIENCY | Author keyword | 41 | 50% | 2% | 59 |
10 | TESTOSTERONE GEL | Author keyword | 41 | 81% | 1% | 25 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HYPOGONADISM | 181 | 34% | 14% | 428 | Search HYPOGONADISM | Search HYPOGONADISM |
2 | LATE ONSET HYPOGONADISM | 127 | 82% | 2% | 75 | Search LATE+ONSET+HYPOGONADISM | Search LATE+ONSET+HYPOGONADISM |
3 | TESTOSTERONE REPLACEMENT THERAPY | 114 | 75% | 3% | 82 | Search TESTOSTERONE+REPLACEMENT+THERAPY | Search TESTOSTERONE+REPLACEMENT+THERAPY |
4 | TESTOSTERONE DEFICIENCY | 108 | 79% | 2% | 70 | Search TESTOSTERONE+DEFICIENCY | Search TESTOSTERONE+DEFICIENCY |
5 | ANDROPAUSE | 75 | 62% | 3% | 78 | Search ANDROPAUSE | Search ANDROPAUSE |
6 | TESTOSTERONE DEFICIENCY SYNDROME | 67 | 89% | 1% | 31 | Search TESTOSTERONE+DEFICIENCY+SYNDROME | Search TESTOSTERONE+DEFICIENCY+SYNDROME |
7 | ANDROGEN DEFICIENCY | 41 | 50% | 2% | 59 | Search ANDROGEN+DEFICIENCY | Search ANDROGEN+DEFICIENCY |
8 | TESTOSTERONE GEL | 41 | 81% | 1% | 25 | Search TESTOSTERONE+GEL | Search TESTOSTERONE+GEL |
9 | AGING MALE | 36 | 59% | 1% | 41 | Search AGING+MALE | Search AGING+MALE |
10 | MALE HYPOGONADISM | 28 | 49% | 1% | 41 | Search MALE+HYPOGONADISM | Search MALE+HYPOGONADISM |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HYPOGONADAL MEN | 355 | 48% | 18% | 537 |
2 | LATE ONSET HYPOGONADISM | 334 | 74% | 8% | 248 |
3 | LOW SERUM TESTOSTERONE | 285 | 73% | 7% | 217 |
4 | ANDROGEN DEFICIENCY | 270 | 64% | 9% | 268 |
5 | ENDOGENOUS SEX HORMONES | 152 | 48% | 8% | 233 |
6 | SERUM TESTOSTERONE | 151 | 31% | 13% | 407 |
7 | SYMPTOMATIC ANDROGEN DEFICIENCY | 144 | 93% | 2% | 54 |
8 | OLDER MEN | 142 | 20% | 20% | 624 |
9 | HORMONE BINDING GLOBULIN | 122 | 23% | 15% | 468 |
10 | TESTOSTERONE REPLACEMENT THERAPY | 106 | 53% | 5% | 139 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AGING MALE | 47 | 37% | 3% | 104 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis | 2011 | 150 | 49 | 82% |
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials | 2013 | 90 | 83 | 72% |
Testosterone and metabolic syndrome | 2015 | 3 | 44 | 86% |
Testosterone Deficiency in Men: Systematic Review and Standard Operating Procedures for Diagnosis and Treatment | 2013 | 56 | 173 | 77% |
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis | 2014 | 20 | 126 | 80% |
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis | 2010 | 230 | 62 | 68% |
Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline | 2006 | 446 | 99 | 78% |
Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study | 2014 | 20 | 110 | 75% |
A Critical Analysis of the Role of Testosterone in Erectile Function: From Pathophysiology to Treatment-A Systematic Review | 2014 | 24 | 80 | 64% |
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study | 2011 | 90 | 114 | 69% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ROBERT HAGUE DIABET ENDOCRINOL | 53 | 95% | 0.6% | 18 |
2 | MENS HLTH BOSTON | 24 | 91% | 0.3% | 10 |
3 | PL UROL | 16 | 64% | 0.5% | 16 |
4 | SCI AFFAIRS MENS HEALTHCARE | 13 | 69% | 0.4% | 11 |
5 | CLIN UROL ANDROL | 11 | 67% | 0.3% | 10 |
6 | GLOBAL MED AFFAIRS ANDROL | 11 | 100% | 0.2% | 6 |
7 | MENS HEALTHCARE | 11 | 100% | 0.2% | 6 |
8 | SEXUAL MED ANDROL UNIT | 10 | 28% | 1.0% | 30 |
9 | SECT ENDOCRINOL DIABET NUTR | 8 | 15% | 1.6% | 49 |
10 | ANDROL UNIT | 8 | 11% | 2.1% | 63 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000244701 | SHBG GENE POLYMORPHISM//CLIN MED CHEM MED//ENDOCRINE SECT INTERNAL MED 3 |
2 | 0.0000139134 | ENT HEAD NECK CANC//AIDS PREVENT CONTROL COMM//DERMATOL VENERIOL |
3 | 0.0000101466 | MALE CONTRACEPTION//VAS OCCLUSION//MALE HORMONAL CONTRACEPTION |
4 | 0.0000085715 | AROMATASE DEFICIENCY//MALE OSTEOPOROSIS//INTEGRATED MED ENDOCRINOL METAB GERIATR |
5 | 0.0000084468 | SELECTIVE ANDROGEN RECEPTOR MODULATOR//SARM//SARMS |
6 | 0.0000077749 | DETECTION ORIENTED DERIVATIZATION//ISOTOPE CODED DERIVATIZATION//DEUTERATED STEROIDS |
7 | 0.0000075385 | ERECTILE DYSFUNCTION//INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH//VARDENAFIL |
8 | 0.0000067418 | SALIVARY TESTOSTERONE//CHALLENGE HYPOTHESIS//HUMAN COMPETITION |
9 | 0.0000066818 | CORTICOSTEROID BINDING GLOBULIN//SEX STEROID BINDING PROTEIN//SEX HORMONE BINDING GLOBULIN |
10 | 0.0000060086 | UNIV INTEGRATED HOSP//DUKE PROSTATE//FREE TESTOSTERONE FT |